Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -6.18-66.140.2217.80-9.90

What is the latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLENMARK PHARMACEUTICALS is -6.18 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-6.18
Mar2023-66.14
Mar20220.22
Mar202117.80
Mar2020-9.90

How is EBIT Growth of GLENMARK PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -6.18
Negative
Mar2023 -66.14
Negative
Mar2022 0.22
-98.76
Mar2021 17.8
Positive
Mar2020 -9.9 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,680.9 Cr -7.3% -4.8% 72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,527.0 Cr -3.8% -3% 34.3% Stock Analytics
DIVIS LABORATORIES ₹156,037.0 Cr 0.9% 0.4% 53.5% Stock Analytics
CIPLA ₹116,854.0 Cr -2.8% -0.1% 9.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,746.0 Cr -2.4% 5.5% 17.5% Stock Analytics
ZYDUS LIFESCIENCES ₹99,093.9 Cr -2.4% -0.3% 42.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-7.3%

-4.8%

72.3%

SENSEX

-1.8%

-6.6%

7.1%


You may also like the below Video Courses